Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 57
Microneedles as Transdermal Drug Delivery System for Enhancing Skin Disease Treatment
Chaoxiong Wu, Qingyu Yu, Chenlu Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5161-5180
Open Access | Times Cited: 18
A Twindrive Precise Delivery System of Platelet-Neutrophil Hybrid Membrane Regulates Macrophage Combined with CD47 Blocking for Postoperative Immunotherapy
Shupei Sheng, Limin Jin, Yan Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 6, pp. 4981-4992
Closed Access | Times Cited: 16
Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma
Hui Wang, Yu Chen, Ran Wei, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 28
Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach
Subhamay Adhikary, Surajit Pathak, Vignesh Palani, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 217-217
Open Access | Times Cited: 10
Dendritic nanomedicine enhances chemo-immunotherapy by disturbing metabolism of cancer-associated fibroblasts for deep penetration and activating function of immune cells
Yunkun Li, Xiaoding Shen, Ding Haitao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3680-3696
Open Access | Times Cited: 10
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
Dual-Responsive Epigenetic Inhibitor Nanoprodrug Combined with Oncolytic Virus Synergistically Boost Cancer Immunotherapy by Igniting Gasdermin E-Mediated Pyroptosis
Yuanyuan Wang, Jingting Wang, Shuo Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 31, pp. 20167-20180
Closed Access | Times Cited: 9
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 8
Selective deficiency of mitochondrial respiratory complex I subunits Ndufs4/6 causes tumor immunogenicity
Jiaxin Liang, Tevis Vitale, Xixi Zhang, et al.
Nature Cancer (2025)
Closed Access | Times Cited: 1
A unified cross-attention model for predicting antigen binding specificity to both HLA and TCR molecules
Chenpeng Yu, Xing Fang, Shiye Tian, et al.
Nature Machine Intelligence (2025)
Closed Access | Times Cited: 1
Understanding the molecular bridges between the drugs and immune cell
Umesh Chandra Dash, Vinayak Nayak, Hiten Shanker Navani, et al.
Pharmacology & Therapeutics (2025) Vol. 267, pp. 108805-108805
Open Access | Times Cited: 1
Small non-coding RNA profiling in patients with non-muscle invasive bladder cancer
Jiajia Cai, Zeqin Yan, Yadi Zhong, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy
Min Yang, Peiluan Zhong, Pengcheng Wei
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2056-2056
Open Access | Times Cited: 1
Precision therapeutic targets for HPV-positive cancers: an overview and new insights
Yaw‐Bin Huang, Jiayi Wang, Wenbin Yang, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 19
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy
Raefa Abou Khouzam, Bassam Janji, Jérôme Thiery, et al.
Seminars in Cancer Biology (2023) Vol. 97, pp. 104-123
Closed Access | Times Cited: 18
Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy
Lele Zhou, Qun Guan, Yu‐Bin Dong
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 8
Closed Access | Times Cited: 17
In-situ vaccination immunotherapy of colorectal cancer with STING agonist-integrated supramolecular nanovectors
Xiaoying Liu, Fangmin Chen, Madiha Saeed, et al.
Nano Today (2024) Vol. 56, pp. 102273-102273
Closed Access | Times Cited: 7
The recent advancements in protein nanoparticles for immunotherapy
Miaomiao Xu, Siyuan Wei, Lifan Duan, et al.
Nanoscale (2024) Vol. 16, Iss. 25, pp. 11825-11848
Closed Access | Times Cited: 6
Light‐Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy
Xian An, Zhuang Chen, Yi Luo, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 6
An Immunomodulatory Zinc‐Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte‐Assisted Cascade Immune Activation
Jing Zhao, Lingxiao Zhang, Li Pin, et al.
Advanced Science (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 14
A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy
Keze Hong, Jianrong Cao, Weiting Jiang, et al.
Journal of Colloid and Interface Science (2024) Vol. 678, pp. 750-762
Closed Access | Times Cited: 5
Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer
Tong Chen, Mingzhao Wang, Yanchao Chen, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top